NuVasive, Inc. (NUVA) Social Stream
NUVASIVE INC (NUVA) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering NUVASIVE INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-10 | 11 | $90 | $48 | $69.583 | $37.12 | 87.45% |
| 2021-11-16 | 11 | $90 | $48 | $67.083 | $37.12 | 80.72% |
| 2021-12-10 | 12 | $90 | $56 | $68.083 | $37.12 | 83.41% |
| 2021-12-17 | 11 | $90 | $50 | $67.25 | $37.12 | 81.17% |
| 2021-12-21 | 9 | $90 | $50 | $66.545 | $37.12 | 79.27% |
| 2022-01-25 | 9 | $90 | $50 | $66.363 | $37.12 | 78.78% |
| 2022-02-15 | 8 | $90 | $50 | $66.363 | $37.12 | 78.78% |
| 2022-02-24 | 9 | $90 | $50 | $66.5 | $37.12 | 79.15% |
| 2022-02-25 | 9 | $80 | $50 | $62.222 | $37.12 | 67.62% |
| 2022-04-11 | 10 | $80 | $50 | $61.8 | $37.12 | 66.49% |
| 2022-04-26 | 10 | $80 | $50 | $62.3 | $37.12 | 67.83% |
| 2022-05-06 | 9 | $80 | $55 | $63.5 | $37.12 | 71.07% |
| 2022-08-02 | 9 | $80 | $54 | $62 | $37.12 | 67.03% |
| 2022-09-17 | 10 | $65 | $54 | $59.545 | $37.12 | 60.41% |
| 2022-10-03 | 10 | $65 | $45 | $57.636 | $37.12 | 55.27% |
| 2022-10-05 | 10 | $65 | $45 | $58.083 | $37.12 | 56.47% |
| 2022-10-07 | 11 | $65 | $45 | $56.923 | $37.12 | 53.35% |
| 2022-10-11 | 12 | $65 | $45 | $56.923 | $37.12 | 53.35% |
| 2022-10-12 | 12 | $65 | $45 | $56.071 | $37.12 | 51.05% |
| 2022-10-18 | 13 | $65 | $45 | $55.866 | $37.12 | 50.5% |
| 2022-12-14 | 13 | $63 | $38 | $50.533 | $37.12 | 36.13% |
| 2023-01-06 | 13 | $63 | $38 | $49.6 | $37.12 | 33.62% |
| 2023-01-26 | 13 | $63 | $38 | $49.6 | $37.12 | 33.62% |
| 2023-02-08 | 12 | $63 | $38 | $49.8 | $37.12 | 34.16% |
| 2023-02-10 | 12 | $63 | $38 | $51.281 | $37.12 | 38.15% |
| 2023-02-15 | 13 | $58 | $38 | $49.881 | $37.12 | 34.38% |
| 2023-02-24 | 13 | $58 | $42 | $50.648 | $37.12 | 36.44% |
| 2023-05-10 | 13 | $58 | $42 | $50.248 | $37.12 | 35.37% |
| 2023-05-15 | 13 | $58 | $42 | $50.314 | $37.12 | 35.54% |
The Trend in the Analyst Price Target
Over the past 18 months, NUVA's average price target has gone down $19.27.
Over the past 43 weeks, NUVA's average upside potential has been 23.07%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-08-02 | 9 | 80 | 54 | 62.000 | 53.15 | 16.65% |
| 2022-09-17 | 9 | 65 | 54 | 59.545 | 46.84 | 27.12% |
| 2022-10-07 | 11 | 65 | 45 | 56.923 | 40.01 | 42.27% |
| 2022-10-18 | 13 | 65 | 45 | 55.866 | 42.52 | 31.39% |
| 2023-02-10 | 12 | 63 | 38 | 51.281 | 44.40 | 15.5% |
NUVA Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.46 | 3 | 1 | 9 | 0 | 0 | 13 |
The Trend in the Broker Recommendations
Over the past 31 months, NUVA's average broker recommendation rating worsened by 0.24.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for NUVA as an investment opportunity.
- NUVA has a greater number of analysts covering the stock than 3135.25% of stocks in the mid market cap category.
- In terms of how NUVASIVE INC fares relative to stocks in the mid market cap category, note that its average analyst price target is higher than 2660.03% of that group.
- NUVASIVE INC's variance in analysts' estimates is lower than -2106.04% of Medical Equipment stocks.
- In terms of how NUVASIVE INC fares relative to stocks in the mid market cap category, note that its upside potential (average analyst target price relative to current price) is higher than 2277.12% of that group.
In terms of price targets and recommendations offered by analysts, the stocks in the Medical Equipment industry with the ratings most similar to NUVASIVE INC are INO, IART, and ICUI.
View All Top Stocks by Price Target
Is NUVA a Buy, Hold or Sell? See the POWR Ratings now!